General Movements in preterm infants undergoing craniosacral therapy: a randomised controlled pilot-trial

Wolfgang Raith, Peter B Marschik, Constanze Sommer, Ute Maurer-Fellbaum, Claudia Amhofer, Alexander Avian, Elisabeth Löwenstein, Susanne Soral, Wilhelm Müller, Christa Einspieler, Berndt Urlesberger, Wolfgang Raith, Peter B Marschik, Constanze Sommer, Ute Maurer-Fellbaum, Claudia Amhofer, Alexander Avian, Elisabeth Löwenstein, Susanne Soral, Wilhelm Müller, Christa Einspieler, Berndt Urlesberger

Abstract

Background: The objective of this study was to investigate neurological short-term effects of craniosacral therapy as an ideal form of osteopathic manipulative treatment (OMT) due to the soft kinaesthetic stimulation.

Methods: Included were 30 preterm infants, with a gestational age between 25 and 33 weeks, who were admitted to the neonatal intensive care unit of the University Hospital of Graz, Austria. The infants were randomized either into the intervention group (IG) which received standardised craniosacral therapy, or the control group (CG) which received standard care. To guarantee that only preterm infants with subsequent normal neurodevelopment were included, follow up was done regularly at the corrected age (= actual age in weeks minus weeks premature) of 12 and 24 months. After 2 years 5 infants had to be excluded (IG; n = 12; CG: n = 13). General Movements (GMs) are part of the spontaneous movement repertoire and are present from early fetal life onwards until the end of the first half year of life. To evaluate the immediate result of such an intervention, we selected the General Movement Assessment (GMA) as an appropriate tool. Besides the global GMA (primary outcome) we used as detailed GMA, the General Movement Optimality Score (GMOS- secondary outcome), based on Prechtl's optimality concept. To analyse GMOS (secondary outcome) a linear mixed model with fixed effects for session, time point (time point refers to the comparisons of the measurements before vs. after each session) and intervention (IG vs. CG), random effect for individual children and a first order autoregressive covariance structure was used for calculation of significant differences between groups and interactions. Following interaction terms were included in the model: session*time point, session*intervention, time point*intervention and session*time point*intervention. Exploratory post hoc analyses (interaction: session*time point*intervention) were performed to determine group differences for all twelve measurement (before and after all 6 sessions) separately.

Results: Between groups no difference in the global GMA (primary outcome) could be observed. The GMOS (secondary outcome) did not change from session to session (main effect session: p = 0.262) in the IG or the CG. Furthermore no differences between IG and CG (main effect group: p = 0.361) and no interaction of time*session could be observed (p = 0.658). Post hoc analysis showed a trend toward higher values before (p = 0.085) and after (p = 0.075) the first session in CG compared to IG. At all other time points GMOS were not significantly different between groups.

Conclusion: We were able to indicate that a group of "healthy" preterm infants undergoing an intervention with craniosacral therapy (IG) showed no significant changes in GMs compared to preterm infants without intervention (CG). In view of the fact that the global GMA (primary outcome) showed no difference between groups and the GMOS (detailed GMA-secondary outcome) did not deteriorate in the IG, craniosacral therapy seems to be safe in preterm infants.

Trial registration: German Clinical Trials Register DRKS00004258 .

Figures

Fig. 1
Fig. 1
Flowchart and study design. CST = craniosacral therapy
Fig. 2
Fig. 2
Secondary outcome: Course of GMOS in Intervention Group (IG) and Control Group (CG). GMOS did not change from session to session (main effect session: p =0.262) in either group. x-axis: 6 episodes of video assessment during study period of 3 weeks (B = Before Intervention, A = After Intervention). y-axis: GMOS Score. The symbols represent medians and the variations represent the interquartile (P25, P75)

References

    1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371:261–9. doi: 10.1016/S0140-6736(08)60136-1.
    1. Field T, Diego M, Hernandez-Reif M. Preterm infant massage therapy research: a review. Infant Behav Dev. 2010;33(2):115–24. doi: 10.1016/j.infbeh.2009.12.004.
    1. Fucile S, Gisel EG. Sensorimotor interventions improve growth and motor function in preterm infants. Neonatal Netw. 2010;29(6):359–66. doi: 10.1891/0730-0832.29.6.359.
    1. Scafidi FA, Field T, Schanberg SM. Factors that predict which preterm infant benefits most from massage therapy. J Dev Behav Pediatr. 1993;14:176–80. doi: 10.1097/00004703-199306010-00008.
    1. Vickers A, Ohlsson A, Lacy JB, Horsley A. Massage for promoting growth and development of preterm and/or low birth-weight infants. Cochrane Database Syst Rev. 2004;2:CD000390.
    1. Clinical Guideline Subcommittee on Low Back Pain; American Osteopathic Association American Osteopathic Association guidelines for osteopathic manipulative treatment(OMT) for patients with low back pain. J Am Osteopath Assoc. 2010;110(Suppl 11):653–66.
    1. Posadzki P, Lee MS, Ernst E. Osteopathic manipulative treatment for pediatric conditions: a systematic review. Pediatrics. 2013;132(Suppl 1):140–52. doi: 10.1542/peds.2012-3959.
    1. Pizzolorusso G, Turi P, Barlafante G, Cerritelli F, Renzetti C, Cozzolino V, et al. Effect of osteopathic manipulative treatment on gastrointestinal function and length of stay of preterm infants: an exploratory study. Chiropr Man Therap. 2011;19(Suppl 1):15. doi: 10.1186/2045-709X-19-15.
    1. Magoun H. Osteopathy in the Cranial Field. Kirksville: Journal Printing Co; 1976.
    1. Cerritelli F, Martelli M, Renzetti C, Pizzolorusso G, Cozzolino V, Barlafante G. Introducing an osteopathic approach into neonatology ward: the NE-O model. Chiropr Man Therap. 2014;22:18. doi: 10.1186/2045-709X-22-18.
    1. Ward RC, Hruby RJ, Jerome JA, Jones JM, Kappler RE, Kuchera ML, et al. Foundations for Osteopathic Medicine, 2nd edition. Lippincott Williams; 2002.
    1. Sutherland WG. The Cranial Bowl. Mankato, USA: The Free Press; 1939.
    1. Upledger JE, Vredevoogd JD. Craniosacral therapy. Seattle, Washington, USA: Eastland Press; 1983.
    1. Frymann VM. A study of the rhythmic motions of the living cranium. J Am Osteopath Assoc. 1971;70(Suppl 9):928–45.
    1. Einspieler C, Prechtl HFR, Bos AF, Ferrari F, Cioni G. Prechtl’s method on the qualitative assessment of general movements in preterm, term and young infants. London: MacKeith Press, distributed by Cambridge University Press. Clin Dev Med. 2004;167:1–91.
    1. Spittle AJ, Doyle LW, Boyd RN. A systematic review of the clinimetric properties of neuromotor assessments for preterm infants during the first year of life. Dev Med Child Neurol. 2008;50:254–66. doi: 10.1111/j.1469-8749.2008.02025.x.
    1. Prechtl HFR. Qualitative changes of spontaneous movements in fetus and preterm infant are a marker of neurological dysfunction. Early Hum Dev. 1990;23:151–8. doi: 10.1016/0378-3782(90)90011-7.
    1. Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997;10(Suppl 349):1361–3. doi: 10.1016/S0140-6736(96)10182-3.
    1. Bosanquet M, Copeland L, Ware R, Boyd R. A systematic review of tests to predict cerebral palsy in young children. Dev Med Child Neurol. 2013;55(Suppl 5):418–26. doi: 10.1111/dmcn.12140.
    1. Spittle AJ, Boyd RN, Inder TE, Doyle LW. Predicting motor development in very preterm infants at 12 months’ corrected age: the role of qualitative magnetic resonanceimaging and general movement assessment. Pediatrics. 2009;123(Suppl 2):512–7. doi: 10.1542/peds.2008-0590.
    1. Engle WA, American Academy of Pediatrics Committee on Fetus and Newborn Age terminology during the perinatal period. Pediatrics. 2004;114(Suppl 5):1362–4.
    1. Touwen BCL. Clinics in developmental medicine. London: Heinemann; 1976. Neurological Development in infancy; p. 58.
    1. Bayley N. Bayley Scales of Infant and Toddler Development. 3. San Antonio: Psychological Corporation; 2006.
    1. UpledgerJ. A Brain is born. Exploring the Birth and Development of the Central Nervous System. North Atlantic BooksBerkeley, California, 1st ed.1996. p. 219-22.
    1. Einspieler C, Prechtl HF. Prechtl’s assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev. 2005;11(Suppl 1):61–7. doi: 10.1002/mrdd.20051.
    1. Prechtl HFR. The organization of behavioural states and their dysfunction. Semin Perinatol. 1992;16:258–63.
    1. Einspieler C, Prechtl HF, Ferrari F, Cioni G, Bos AF. The qualitative assessment of general movements in preterm, term and young infants-review of the methodology. Early Hum Dev. 1997;50:47–60. doi: 10.1016/S0378-3782(97)00092-3.
    1. Einspieler C, Marschik PB, Pansy J, Scheuchenegger A, Krieber M, Yang H, et al. The general movement optimality score: a detailed assessment of general movements during preterm and term age. Dev Med Child Neurol. 2015
    1. Bos AF, Martijn A, Okken A, Prechtl HFR. Quality of general movements in preterm infants with transient periventricular echodensities. Acta Paediatr. 1998;87(Suppl 43):328–35. doi: 10.1111/j.1651-2227.1998.tb01447.x.
    1. Cioni G, Bos AF, Einspieler C, Ferrari F, Martijn A, Paolicelli PB, et al. Early neurological signs in preterm infants with unilateral intraparenchymal echodensity. Neuropediatrics. 2000;31(Suppl 5):240–51. doi: 10.1055/s-2000-9233.
    1. Einspieler C, Cioni G, Paolicelli PB, Bos AF, Dressler A, Ferrari F, et al. The early markers for later dyskinetic cerebral palsy are different from those for spastic cerebral palsy. Neuropediatrics. 2002;33(Suppl 2):73–8. doi: 10.1055/s-2002-32368.
    1. Burger M, Louw QA. The predictive validity of general movements--a systematic review. Eur J Paediatr Neurol. 2009;13(Suppl 5):408–20. doi: 10.1016/j.ejpn.2008.09.004.
    1. Noble Y, Boyd R. Neonatal assessments for the preterm infant up to 4 months corrected age: a systematic review. Dev Med Child Neurol. 2012;54(Suppl 2):129–39. doi: 10.1111/j.1469-8749.2010.03903.x.
    1. Harrison RE, Page JS. Multipractitioner Upledger CranioSacral Therapy: descriptive outcome study 2007-2008. J Altern Complement Med. 2011;17(Suppl 1):13–27. doi: 10.1089/acm.2009.0644.
    1. Jäkel A, von Hauenschild P. A systematic review to evaluate the clinical benefits of craniosacral therapy. Complement Ther Med. 2012;20(Suppl 6):456–65. doi: 10.1016/j.ctim.2012.07.009.
    1. Zuzak TJ, Boňková J, Careddu D, Garami M, Hadjipanayis A, Jazbec J, et al. Use of complementary and alternative medicine by children in Europe: published data and expert perspectives. Complement Ther Med. 2013;21(Suppl 1):34–47. doi: 10.1016/j.ctim.2012.01.001.
    1. Lund GC, Edwards G, Medlin B, Keller D, Beck B, Carreiro JE. Osteopathic manipulative treatment for the treatment of hospitalized premature infants with nipple feeding dysfunction. J Am Osteopath Assoc. 2011;111(Suppl 1):44–8.
    1. Potzinger S. Familiarity with craniosacral nursing in pediatric nursing (in german) Kinderkrankenschwester. 2008;27(Suppl 12):504.
    1. Hayden C, Mullinger B. A preliminary assessment of the impact of cranial osteopathy for the relief of infantile colic. Complement Ther Clin Pract. 2006;12(Suppl 2):83–90. doi: 10.1016/j.ctcp.2005.12.005.
    1. Vandenplas Y, Denayer E, Vandenbossche T, Vermet L, Hauser B, Deschepper J, et al. Osteopathy may decrease obstructive apnea in infants: a pilot study. Osteopath Med Prim Care. 2008
    1. Philippi H, Faldum A, Schleupen A, Pabst B, Jung T, Bergmann H, et al. Infantile postural asymmetry and osteopathic treatment: a randomized therapeutic trial. Dev Med Child Neurol. 2006;48(Suppl 1):5–9.
    1. Cerritelli F, Pizzolorusso G, Ciardelli F, La Mola E, Cozzolino V, Renzetti C, et al. Effect of osteopathic manipulative treatment on length of stay in a population of preterm infants: a randomized controlled trial. BMC Pediatr. 2013;13:65. doi: 10.1186/1471-2431-13-65.
    1. Cerritelli F, Pizzolorusso G, Renzetti C, D’Incecco C, Fusilli P, Perri PF, et al. Effectiveness of osteopathic manipulative treatment in neonatal intensive care units: protocol for a multicentre randomised clinical trial. BMJ Open. 2013;3(2).
    1. Narendran V, Visscher MO, Abril I, Hendrix SW, Hoath SB. Biomarkers of epidermal innate immunity in premature and full-term infants. Pediatr Res. 2010;67(Suppl 4):382–6. doi: 10.1203/PDR.0b013e3181d00b73.
    1. Meltzer KR, Standley PR. Modeled repetitive motion strain and indirect osteopathic manipulative techniques in regulation of human fibroblast proliferation and interleukin secretion. J Am Osteopath Assoc. 2007;107(Suppl 12):527–36.
    1. Degenhardt BF, Darmani NA, Johnson JC, Towns LC, Rhodes DC, Trinh C, et al. Role of osteopathic manipulative treatment in altering pain biomarkers: a pilot study. J Am Osteopath Assoc. 2007;107(Suppl 9):387–400.
    1. Longin E, Gerstner T, Schaible T, Lenz T, Konig S. Maturation of the autonomic nervous system: differences in heart rate variability in premature vs. term infants. J Perinat Med. 2006;34(Suppl 4):303–8.
    1. Henley CE, Ivins D, Mills M, Wen FK, Benjamin BA. Osteopathic manipulative treatment and its relationship to autonomic nervous system activity as demonstrated by heart rate variability: a repeated measures study. Osteopath Med Prim Care. 2008;2:7. doi: 10.1186/1750-4732-2-7.
    1. Girsberger W, Bänziger U, Lingg G, Lothaller H, Endler PC. Heart rate variability and the influence of craniosacral therapy on autonomous nervous system regulation in persons with subjective discomforts: a pilot study. J Integr Med. 2014;12(Suppl 3):156–61. doi: 10.1016/S2095-4964(14)60021-2.
    1. de Vries NK, Bos AF. The quality of general movements in the first ten days of life in preterm infants. Early Hum Dev. 2010;86(Suppl 4):225–9. doi: 10.1016/j.earlhumdev.2010.03.004.
    1. Nakajima Y, Einspieler C, Marschik PB, Bos AF, Prechtl HF. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally. Early Hum Dev. 2006;86(Suppl 1):53–9. doi: 10.1016/j.earlhumdev.2005.07.010.
    1. Ferrari F, Cioni G, Einspieler C, Roversi MF, Bos AF, Paolicelli PB, et al. Cramped synchronized general movements in preterm infants as an early marker for cerebral palsy. Arch Pediatr Adolesc Med. 2002;156(Suppl 5):460–7. doi: 10.1001/archpedi.156.5.460.
    1. Bos AF, Dibiasi J, Tiessen AH, Bergman KA. Treating preterm infants at risk for chronic lung disease with dexamethasone leads to an impaired quality of general movements. Biol Neonate. 2002;82(Suppl 3):155–8. doi: 10.1159/000063612.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Statist. 2005;4(Suppl 4):287–91. doi: 10.1002/pst.185.
    1. Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013;13:104. doi: 10.1186/1471-2288-13-104.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe